In conclusion, our study establishes that EBV‐miR‐BART18‐3p functions as an oncogenic factor in CRC development by upregulating LDHA‐mediated metabolic processes and the FASN‐mediated de novo lipogenesis pathway. This evidence concerns the gene LDHA and colorectal carcinoma.